Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2016New England Journal of MedicineOpen Access

Biologic and Clinical Perspectives on Thyroid Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJames A. FaginUlsan CollegeSWSamuel A. WellsSouthern Utah University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fagin et al. (2016) studied this question.

synapsesocial.com/papers/69d8a88a18b0ca7f91d18bc9https://doi.org/10.1056/nejmra1501993
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System2010 · 940 citations
  2. 2Highly prevalent TERT promoter mutations in aggressive thyroid cancers2013 · 618 citations
  3. 3Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders2004 · 542 citations
  4. 4<i>BRAF</i> V600E and <i>TERT</i> Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence2014 · 726 citations
  5. 5Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*2000 · 75 citations